Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2013 October;61(5) > Minerva Cardioangiologica 2013 October;61(5):499-512

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

  TAVI 2013: WHERE ARE WE NOW? PART II 

Minerva Cardioangiologica 2013 October;61(5):499-512

Copyright © 2013 EDIZIONI MINERVA MEDICA

language: English

Role of balloon postdilation following trancatheter aortic valve implantation

Nombela-Franco L., Barbosa Ribeiro H., Allende R., Urena M., Doyle D., Dumont E., Delarochellière R., Rodés-Cabau J.

Quebec Heart and Lung Institute, Quebec City, QC, Canada


PDF


Paravalvular aortic regurgitation (AR) is a frequent complication following transcatheter aortic valve implantation (TAVI) with an incidence of mild to moderate AR almost systematically higher than 30%. Moreover, several studies have shown that AR has a negative impact on short and mid-term mortality. Balloon postdilation has been proposed as an initial periprocedural option for patients with paravalvular AR to obtain a better expansion of the stent valve frame and potentially reduce the severity of the leak. The aim of this review is to discuss the current available literature on balloon postdilation as a treatment of paravalvular AR after TAVI, its impact on clinical events and future perspectives.

top of page